Alidac Pharmaceuticals' Ahmedabad facility completes USFDA inspection
With Zero observations
Cadila Healthcare announced that the USFDA inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, located at SEZ, Ahmedabad from 27 January to 4 February 2020. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectable for the regulated markets.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 05 2020 | 10:52 AM IST